Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications

Background: Non-proliferative diabetic retinopathy (NPDR) is a significant complication of long-term diabetes in Sudan. This study aimed to determine the prevalence and risk factors of diabetic retinopathy among Sudanese individuals with type 2 diabetes mellitus who are taking oral antidiabetic med...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa Tag E. Elkhider, Musaab Ahmed, Safaa Badi, Mohamed Hyder Abu Ahmed, Hanan Tahir, Heitham Awadalla, Nuha Eljaili Abubaker, Mohammed Seed Seed Ahmed, Mohamed H Ahmed, Ahmed O. Almobarak
Format: Article
Language:English
Published: Knowledge E 2025-06-01
Series:Sudan Journal of Medical Sciences
Subjects:
Online Access:https://knepublishing.com/index.php/SJMS/article/view/18369
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850108712422735872
author Alaa Tag E. Elkhider
Musaab Ahmed
Safaa Badi
Mohamed Hyder Abu Ahmed
Hanan Tahir
Heitham Awadalla
Nuha Eljaili Abubaker
Mohammed Seed Seed Ahmed
Mohamed H Ahmed
Ahmed O. Almobarak
author_facet Alaa Tag E. Elkhider
Musaab Ahmed
Safaa Badi
Mohamed Hyder Abu Ahmed
Hanan Tahir
Heitham Awadalla
Nuha Eljaili Abubaker
Mohammed Seed Seed Ahmed
Mohamed H Ahmed
Ahmed O. Almobarak
author_sort Alaa Tag E. Elkhider
collection DOAJ
description Background: Non-proliferative diabetic retinopathy (NPDR) is a significant complication of long-term diabetes in Sudan. This study aimed to determine the prevalence and risk factors of diabetic retinopathy among Sudanese individuals with type 2 diabetes mellitus who are taking oral antidiabetic medication. Methods: This cross-sectional, facility-based study recruited 196 individuals with type 2 diabetes at the Jabir Abu Eliz Diabetes Health Center in Khartoum State. Data were collected through a structured questionnaire, which patients filled out after providing informed consent. The data were analyzed using the Statistical Package for the Social Sciences (SPSS). Logistic regression was performed to predict factors associated with diabetic retinopathy. Results: The mean age of the patients was 50.1 ± 10.7 years. The prevalence of NPDR was 78 (39.8%). Bivariate analysis revealed that age, education level, and residence (Pvalue < 0.05) were significantly associated with diabetic retinopathy. Additional factors that were significantly associated with diabetic retinopathy included the duration of diabetes, the presence of other comorbidities, HbA1c, and fasting blood glucose in 68 (87.2%) individuals (P-value < 0.05). Conclusion: The study revealed a prevalence of 39.8% for NPDR in this cohort. A longer duration of diabetes and poor control are the primary risk factors for diabetic retinopathy in Sudan. Further research is necessary to determine whether intensifying therapy or administering insulin may reduce the prevalence of retinopathy.
format Article
id doaj-art-2a41d41a4c6649fc9003759cf194e860
institution OA Journals
issn 1858-5051
language English
publishDate 2025-06-01
publisher Knowledge E
record_format Article
series Sudan Journal of Medical Sciences
spelling doaj-art-2a41d41a4c6649fc9003759cf194e8602025-08-20T02:38:18ZengKnowledge ESudan Journal of Medical Sciences1858-50512025-06-0120210.18502/sjms.v20i2.18369Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic MedicationsAlaa Tag E. Elkhider0https://orcid.org/0009-0006-7691-6551Musaab Ahmed1https://orcid.org/0000-0002-2300-9919Safaa Badi2https://orcid.org/0000-0003-3204-983XMohamed Hyder Abu Ahmed3Hanan Tahir4Heitham Awadalla5Nuha Eljaili Abubaker6Mohammed Seed Seed Ahmed7https://orcid.org/0000-0001-7179-9735Mohamed H Ahmed8Ahmed O. Almobarak9Department of Health Abu Dhabi, Healthline Medical Group, Abu DhabiCollege of MedicineDepartment of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, KhartoumDepartment of Pathology, Faculty of Medicine, University of Khartoum, KhartoumImtar Academy, RiyadhDepartment of Community Medicine, Faculty of Medicine, University of Khartoum, KhartoumClinical Chemistry Department, College of Medical Laboratory Science, Sudan University of Science and Technology, KhartoumDepartment of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, DohaDepartment of Geriatric Medicine, Milton Keynes University Hospital NHS Foundation Trust, Eaglestone, Milton Keynes, BuckinghamshireDepartment of Pathology, Faculty of Medicine, University of Medical Sciences and Technology, Khartoum Background: Non-proliferative diabetic retinopathy (NPDR) is a significant complication of long-term diabetes in Sudan. This study aimed to determine the prevalence and risk factors of diabetic retinopathy among Sudanese individuals with type 2 diabetes mellitus who are taking oral antidiabetic medication. Methods: This cross-sectional, facility-based study recruited 196 individuals with type 2 diabetes at the Jabir Abu Eliz Diabetes Health Center in Khartoum State. Data were collected through a structured questionnaire, which patients filled out after providing informed consent. The data were analyzed using the Statistical Package for the Social Sciences (SPSS). Logistic regression was performed to predict factors associated with diabetic retinopathy. Results: The mean age of the patients was 50.1 ± 10.7 years. The prevalence of NPDR was 78 (39.8%). Bivariate analysis revealed that age, education level, and residence (Pvalue < 0.05) were significantly associated with diabetic retinopathy. Additional factors that were significantly associated with diabetic retinopathy included the duration of diabetes, the presence of other comorbidities, HbA1c, and fasting blood glucose in 68 (87.2%) individuals (P-value < 0.05). Conclusion: The study revealed a prevalence of 39.8% for NPDR in this cohort. A longer duration of diabetes and poor control are the primary risk factors for diabetic retinopathy in Sudan. Further research is necessary to determine whether intensifying therapy or administering insulin may reduce the prevalence of retinopathy. https://knepublishing.com/index.php/SJMS/article/view/18369diabetic retinopathydiabetesprevalencerisk factorsduration
spellingShingle Alaa Tag E. Elkhider
Musaab Ahmed
Safaa Badi
Mohamed Hyder Abu Ahmed
Hanan Tahir
Heitham Awadalla
Nuha Eljaili Abubaker
Mohammed Seed Seed Ahmed
Mohamed H Ahmed
Ahmed O. Almobarak
Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications
Sudan Journal of Medical Sciences
diabetic retinopathy
diabetes
prevalence
risk factors
duration
title Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications
title_full Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications
title_fullStr Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications
title_full_unstemmed Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications
title_short Prevalence and Risk Factors of Non-proliferative Diabetic Retinopathy in Individuals with Type 2 Diabetes Mellitus Taking Oral Antidiabetic Medications
title_sort prevalence and risk factors of non proliferative diabetic retinopathy in individuals with type 2 diabetes mellitus taking oral antidiabetic medications
topic diabetic retinopathy
diabetes
prevalence
risk factors
duration
url https://knepublishing.com/index.php/SJMS/article/view/18369
work_keys_str_mv AT alaatageelkhider prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT musaabahmed prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT safaabadi prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT mohamedhyderabuahmed prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT hanantahir prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT heithamawadalla prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT nuhaeljailiabubaker prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT mohammedseedseedahmed prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT mohamedhahmed prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications
AT ahmedoalmobarak prevalenceandriskfactorsofnonproliferativediabeticretinopathyinindividualswithtype2diabetesmellitustakingoralantidiabeticmedications